Should You Buy X4 Pharmaceuticals (XFOR) After Golden Cross?

Group 1 - X4 Pharmaceuticals, Inc. (XFOR) has reached a key level of support, indicating a potential bullish breakout as its 50-day simple moving average has crossed above its 200-day simple moving average, forming a "golden cross" [1] - A golden cross signifies a trend reversal, starting from a downtrend, followed by the shorter moving average crossing above the longer moving average, and culminating in an upward price movement [2] - XFOR shares have increased by 8.4% over the past four weeks, and the company holds a 3 (Hold) rating on the Zacks Rank, suggesting a potential for further gains [3] Group 2 - There have been four upward revisions in earnings expectations for XFOR in the current quarter, with no downward revisions, indicating a positive sentiment among investors [3] - The Zacks Consensus Estimate for XFOR has also moved up, reinforcing the bullish outlook for the company [5]